Predictors of ≥48-hour interruptions MEMS adherence included in the multivariable model.

<p>Values indicate odds ratios with 95% confidence intervals in parentheses.</p>*<p>Could not be estimated in the multivariate model due to inadequate variation in values.</p><p>Bold indicates p<0.05.</p

Figure 1

<p>Study participants.</p

Median adherence for the cohort by multiple measures.

<p>The interquartile range is shown in parentheses.</p><p>VAS  =  visual analog scale.</p

Figure 2

<p>Detectable HIV RNA by ART history at enrollment.</p

Characteristics of the child, regimen, caregiver, and household/community.

*<p>N = sample used for determining each characteristic, IQR = interquartile range, FDC = fixed drug combination, UgSh = Ugandan Shillings.</p>1<p>Most common symptoms were cough, weakness/tiredness, and skin problems.</p>2<p>Co-trimoxazole was prescribed to all children on enrollment for prevention of opportunistic and other infections regardless of ARV use.</p>3<p>The most common and consistently endorsed symptom on this scale was “worrying too much about things”.</p>4<p>Defined as >5 drinks (1 glass wine, 333 ml beer, or 40 ml hard liquor).</p>5<p>4000 UgSh equals approximately US$1.60.</p

Correlation among adherence measures and with HIV RNA.

<p>Adherence measures are compared with each other as means for all participants over the duration of the study. Comparisons between mean adherence measures and log HIV RNA reflect adherence in the month prior to the HIV RNA measurement. The first set of values in each box indicates the Spearman correlation coefficient (r).</p><p>VAS  =  visual analog scale.</p><p>Bold indicates p<0.05.</p

Distribution of median adherence by participant using multiple measures.

<p>VAS  =  visual analog scale.</p